Verrica Pharmaceuticals Inc.
VRCA
$5.14
-$0.12-2.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.15M | -9.68M | -8.07M | -274.00K | 204.00K |
| Total Depreciation and Amortization | 207.00K | 194.00K | 190.00K | 184.00K | 199.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.31M | 2.35M | 1.29M | 1.84M | 1.16M |
| Change in Net Operating Assets | -641.00K | -2.02M | 2.01M | 7.93M | -11.61M |
| Cash from Operations | -9.28M | -9.16M | -4.59M | 9.69M | -10.04M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -126.00K | -111.00K | -36.01M | -3.98M | -4.16M |
| Issuance of Common Stock | -- | -- | 50.07M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -9.00K | -420.00K | -- | -- |
| Cash from Financing | -126.00K | -120.00K | 13.64M | -3.98M | -4.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.40M | -9.28M | 9.05M | 5.70M | -14.20M |